Novel dimeric bis(7)-tacrine proton-dependently inhibits NMDA-activated currents.

Jialie Luo,Wenming Li,Yuwei Liu,Wei Zhang,Hongjun Fu,Nelson T K Lee,Hua Yu,Yuanping Pang,Pingbo Huang,Jun Xia,Zhi-Wang Li,Chaoying Li,Yifan Han
DOI: https://doi.org/10.1016/j.bbrc.2007.07.043
IF: 3.1
2007-01-01
Biochemical and Biophysical Research Communications
Abstract:Bis(7)-tacrine has been shown to prevent glutamate-induced neuronal apoptosis by blocking NMDA receptors. However, the characteristics of the inhibition have not been fully elucidated. In this study, we further characterize the features of bis(7)-tacrine inhibition of NMDA-activated current in cultured rat hippocampal neurons. The results show that with the increase of extracellular pH, the inhibitory effect decreases dramatically. At pH 8.0, the concentration–response curve of bis(7)-tacrine is shifted rightwards with the IC50 value increased from 0.19±0.03μM to 0.41±0.04μM. In addition, bis(7)-tacrine shifts the proton inhibition curve rightwards. Furthermore, the inhibitory effect of bis(7)-tacrine is not altered by the presence of the NMDA receptor proton sensor shield spermidine. These results indicate that bis(7)-tacrine inhibits NMDA-activated current in a pH-dependent manner by sensitizing NMDA receptors to proton inhibition, rendering it potentially beneficial therapeutic effects under acidic conditions associated with stroke and ischemia.
What problem does this paper attempt to address?